DEA requirements for EPCS demystified
According to the Centers for Disease Control and Prevention (CDC) there are nearly 23,000 deaths caused by overdoses of prescription medications every year. That's more than the number of deaths from cocaine and heroin combined. States have responded with new legislation, including New York’s I-STOP requirements, which mandate the electronic transmission of all prescriptions, including prescriptions for controlled substances, by March 27, 2016.
To help providers navigate the complex legal requirements of e-prescribing, Imprivata is running a series of “EPCS – Ask the Experts” webinars. In the most recent webinar, Bill Winsley, former Executive Director of the Ohio State Board of Pharmacy, Imprivata CTO, David Ting, and Imprivata Director of Nursing & Clinical Workflow, Chris McKay, answer FAQs relating to Electronic Prescribing of Controlled Substances (EPCS).
Some of the questions they cover include:
- DEA and New York State I-STOP requirements for e-prescribing
- EPCS workflows
- Two-factor authentication
- Pharmacy readiness